BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32728174)

  • 1. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
    Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
    Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
    Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study.
    Usui T; Nagata M; Hata J; Mukai N; Hirakawa Y; Yoshida D; Kishimoto H; Kitazono T; Kiyohara Y; Ninomiya T
    J Atheroscler Thromb; 2017 Jul; 24(7):706-715. PubMed ID: 27840387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
    Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
    Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults.
    Kim JY; Kang HT; Lee HR; Lee YJ; Shim JY
    J Korean Med Sci; 2012 Dec; 27(12):1524-9. PubMed ID: 23255852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dyslipidemia with renal outcomes in chronic kidney disease.
    Chen SC; Hung CC; Kuo MC; Lee JJ; Chiu YW; Chang JM; Hwang SJ; Chen HC
    PLoS One; 2013; 8(2):e55643. PubMed ID: 23390545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria.
    Chen SC; Hung CC; Tsai YC; Huang JC; Kuo MC; Lee JJ; Chiu YW; Chang JM; Hwang SJ; Chen HC
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1915-26. PubMed ID: 23929929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.
    Zuo PY; Chen XL; Liu YW; Zhang R; He XX; Liu CY
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):582-7. PubMed ID: 25921842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
    Navaneethan SD; Schold JD; Walther CP; Arrigain S; Jolly SE; Virani SS; Winkelmayer WC; Nally JV
    J Clin Lipidol; 2018; 12(4):1061-1071.e7. PubMed ID: 29699917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients.
    Chen HY; Tsai WC; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    Medicine (Baltimore); 2015 Mar; 94(10):e619. PubMed ID: 25761189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.
    Zewinger S; Speer T; Kleber ME; Scharnagl H; Woitas R; Lepper PM; Pfahler K; Seiler S; Heine GH; März W; Silbernagel G; Fliser D
    J Am Soc Nephrol; 2014 May; 25(5):1073-82. PubMed ID: 24610925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.